For: | Tomkin GH. Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors. World J Diabetes 2014; 5(5): 636-650 [PMID: 25317241 DOI: 10.4239/wjd.v5.i5.636] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v5/i5/636.htm |
Number | Citing Articles |
1 |
Aristi Boulmpou, Dimitrios Patoulias, Christodoulos E. Papadopoulos, Eleftherios Teperikidis, Michael Doumas, Vassilios Vassilikos. Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias. Acta Cardiologica 2023; 78(5): 519 doi: 10.1080/00015385.2022.2087839
|
2 |
Hyeong-Kyu Park, Rexford S. Ahima. Metabolic Syndrome. 2015; : 1 doi: 10.1007/978-3-319-12125-3_42-1
|
3 |
Verena B. Oliveira, Raquel L.B. Araújo, Thomas Eidenberger, Maria G.L. Brandão. Chemical composition and inhibitory activities on dipeptidyl peptidase IV and pancreatic lipase of two underutilized species from the Brazilian Savannah: Oxalis cordata A.St.-Hil. and Xylopia aromatica (Lam.) Mart. Food Research International 2018; 105: 989 doi: 10.1016/j.foodres.2017.11.079
|
4 |
Hyeong-Kyu Park, Rexford S. Ahima. Metabolic Syndrome. 2016; : 743 doi: 10.1007/978-3-319-11251-0_42
|
5 |
Kai-Jyun Chang, Jer-An Lin, Sheng-Yi Chen, Ming-Hung Weng, Gow-Chin Yen. Silymarin protects against high fat diet-evoked metabolic injury by induction of glucagon-like peptide 1 and sirtuin 1. Journal of Functional Foods 2019; 56: 136 doi: 10.1016/j.jff.2019.03.012
|
6 |
Tilo Moede, Ingo B. Leibiger, Per-Olof Berggren. Alpha cell regulation of beta cell function. Diabetologia 2020; 63(10): 2064 doi: 10.1007/s00125-020-05196-3
|
7 |
Helene Baribault. Mouse Models for Drug Discovery. Methods in Molecular Biology 2016; 1438: 153 doi: 10.1007/978-1-4939-3661-8_10
|
8 |
Jean-Philippe Krieger, Wolfgang Langhans, Shin J. Lee. Novel role of GLP-1 receptor signaling in energy expenditure during chronic high fat diet feeding in rats. Physiology & Behavior 2018; 192: 194 doi: 10.1016/j.physbeh.2018.03.037
|
9 |
Vasiliki Lagou, Longda Jiang, Anna Ulrich, Liudmila Zudina, Karla Sofia Gutiérrez González, Zhanna Balkhiyarova, Alessia Faggian, Jared G. Maina, Shiqian Chen, Petar V. Todorov, Sodbo Sharapov, Alessia David, Letizia Marullo, Reedik Mägi, Roxana-Maria Rujan, Emma Ahlqvist, Gudmar Thorleifsson, Ηe Gao, Εvangelos Εvangelou, Beben Benyamin, Robert A. Scott, Aaron Isaacs, Jing Hua Zhao, Sara M. Willems, Toby Johnson, Christian Gieger, Harald Grallert, Christa Meisinger, Martina Müller-Nurasyid, Rona J. Strawbridge, Anuj Goel, Denis Rybin, Eva Albrecht, Anne U. Jackson, Heather M. Stringham, Ivan R. Corrêa, Eric Farber-Eger, Valgerdur Steinthorsdottir, André G. Uitterlinden, Patricia B. Munroe, Morris J. Brown, Julian Schmidberger, Oddgeir Holmen, Barbara Thorand, Kristian Hveem, Tom Wilsgaard, Karen L. Mohlke, Zhe Wang, Marcel den Hoed, Aleksey Shmeliov, Marcel den Hoed, Ruth J. F. Loos, Wolfgang Kratzer, Mark Haenle, Wolfgang Koenig, Bernhard O. Boehm, Tricia M. Tan, Alejandra Tomas, Victoria Salem, Inês Barroso, Jaakko Tuomilehto, Michael Boehnke, Jose C. Florez, Anders Hamsten, Hugh Watkins, Inger Njølstad, H.-Erich Wichmann, Mark J. Caulfield, Kay-Tee Khaw, Cornelia M. van Duijn, Albert Hofman, Nicholas J. Wareham, Claudia Langenberg, John B. Whitfield, Nicholas G. Martin, Grant Montgomery, Chiara Scapoli, Ioanna Tzoulaki, Paul Elliott, Unnur Thorsteinsdottir, Kari Stefansson, Evan L. Brittain, Mark I. McCarthy, Philippe Froguel, Patrick M. Sexton, Denise Wootten, Leif Groop, Josée Dupuis, James B. Meigs, Giuseppe Deganutti, Ayse Demirkan, Tune H. Pers, Christopher A. Reynolds, Yurii S. Aulchenko, Marika A. Kaakinen, Ben Jones, Inga Prokopenko, Cornelia M. van Duijn. GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification. Nature Genetics 2023; 55(9): 1448 doi: 10.1038/s41588-023-01462-3
|
10 |
Tulika Arora, Udo Wegmann, Anup Bobhate, Ying Shiuan Lee, Thomas U. Greiner, Daniel J. Drucker, Arjan Narbad, Fredrik Bäckhed. Microbially produced glucagon-like peptide 1 improves glucose tolerance in mice. Molecular Metabolism 2016; 5(8): 725 doi: 10.1016/j.molmet.2016.06.006
|
11 |
Anita Y H Lee, Derek L Chappell, Monika J Bak, Michael Judo, Linda Liang, Tatyana Churakova, Gulesi Ayanoglu, Jose Castro-Perez, Haihong Zhou, Stephen Previs, Sandra C Souza, Michael E Lassman, Omar F Laterza. Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test. Clinical Chemistry 2016; 62(1): 227 doi: 10.1373/clinchem.2015.244251
|
12 |
Mini P. Sajan, Barbara C. Hansen, Mildred Acevedo‐Duncan, Mark S. Kindy, Denise R. Cooper, Robert V. Farese. Roles of hepatic atypical protein kinase C hyperactivity and hyperinsulinemia in insulin‐resistant forms of obesity and type 2 diabetes mellitus. MedComm 2021; 2(1): 3 doi: 10.1002/mco2.54
|
13 |
Catherine Arden. A role for Glucagon-Like Peptide-1 in the regulation of β-cell autophagy. Peptides 2018; 100: 85 doi: 10.1016/j.peptides.2017.12.002
|
14 |
Jose Górriz, Javier Nieto, Juan Navarro-González, Pablo Molina, Alberto Martínez-Castelao, Luis Pallardó. Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?. Journal of Clinical Medicine 2015; 4(10): 1866 doi: 10.3390/jcm4101866
|
15 |
ОЦЕНКА ВЛИЯНИЯ ТЕРАПИИ ИНКРЕТИНОМИМЕТИКАМИ И ГЛИФЛОЗИНАМИ НА ФУНКЦИЮ АЛЬФА И БЕТА-КЛЕТОК ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ У ПАЦИЕНТОВ С СД 2 ТИПА . World Science 2021; (3(64)) doi: 10.31435/rsglobal_ws/30032021/7507
|
16 |
Jean Claude Mbanya, Saud Al-Sifri, Aly Abdel-Rahim, Ilhan Satman. Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach. Diabetes Research and Clinical Practice 2015; 109(2): 226 doi: 10.1016/j.diabres.2015.04.030
|
17 |
Kyle S. Burger, Grace E. Shearrer, Jennifer R. Gilbert. Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function. 2018; : 347 doi: 10.1007/978-3-319-89506-2_13
|
18 |
Monica de Gaetano, Caitriona McEvoy, Darrell Andrews, Antonino Cacace, Jonathan Hunter, Eoin Brennan, Catherine Godson. Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01488
|
19 |
Josh Reed, Stephen Bain, Venkateswarlu Kanamarlapudi. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3567 doi: 10.2147/DMSO.S319895
|